Objective: To analyse the relation between antioxidant vitamins A, E, and malondialdehyde (MDA) lipoperoxidation product plasma concentrations with incident dementia. Design: A nested case-control within the PAQUID (Personnes Agées QUID) cohort. Setting: The PAQUID population-based prospective cohort in southwestern France. Subjects: Among 626 subjects with blood collection at baseline, 46 developed a dementia during the follow-up and were considered to be cases. Each case was matched (on age and sex) to three controls. Results: Plasma vitamin E concentrations were lower among cases (mean value at 22.62 mmol/l (s.d.: 7.38) vs 24.99 (s.d.: 6.73 among controls). The same trend was observed for vitamin A concentrations, but the difference was not significant. On the contrary, MDA concentrations tended to be higher (mean value 1.35 mmol/l (s.d.: 0.53) vs 1.23 (s.d.: 0.44)) among cases. In logistic regression models, plasma values were split into tertiles. Adjusted for confounders, the risk of dementia was significantly increased in the lowest vitamin E tertile (r21.0 mmol/l) (OR ¼ 3.12, P ¼ 0.033) compared to the highest one (Z25.5 mmol/l). The risk of Alzheimer's disease was also increased, with borderline significance (OR ¼ 3.06, P ¼ 0.053). Risks associated with vitamin A were nonsignificant. Similarly, there was a trend to an increased risk of dementia in the highest tertile of MDA (OR ¼ 1.67, P ¼ 0.31). Conclusions: These results suggest that subjects with low plasma vitamin E concentrations are at a higher risk of developing a dementia in subsequent years.
Introduction
Ageing is characterized by an increased production of free radicals and a decreased capacity in antioxidant systems contributing to oxidative stress. Many studies have established that oxidative stress is highly implicated in diseases associated with ageing, and lesions that are typically associated with attacks by free radicals have been found in the brains of Alzheimer's patients (Christen, 2000) . Oxidative stress could indeed induce DNA damage, lipoperoxidation, and promote b-amyloïd aggregation. Moreover, amyloïd b protein can directly induce peroxide formation and lipid peroxidation (Behl, 1999) and some authors have shown a correlation between the intensity of free radicals produced by b-amyloïd and neurotoxicity, suggesting that oxidative stress could be a pathway in neuronal death (Goodman and Mattson, 1994) . Similarly, in experimental studies, several antioxidant factors have been reported to reduce neurotoxicity and to prevent learning and memory deficits caused by b-amyloïd in rats (Harkany et al, 1999 , Yamada et al, 1999 . Thus, reducing oxidative stress with nutritional antioxidant factors such as vitamin E could have a beneficial effect in minimizing the pathogenesis of Alzheimer's disease (AD) (Behl, 1999) .
However, epidemiological studies that have investigated the relation between natural antioxidant products and alteration in cognitive performances have given controversial results (Deschamps et al, 2001 ). Some case-control studies have found lower plasma concentration in antioxidant vitamins among AD patients as compared to controls; however, not always the same vitamins were implicated (Zaman et al, 1992 , Riviere et al, 1998 , Bourdel-Marchasson et al, 2001 . Moreover, confounding factors were not taken into account in these studies. More recently, longitudinal studies on dementia and AD have been published. A randomized trial has found that vitamin E supplementation could reduce a combined end point including institutionalization, loss of functional activities, progression of dementia severity and death (Sano et al, 1997) . Some observational studies have found a beneficial effect on the risk of dementia associated with vitamin supplements intake, although this effect has been observed with vitamin C alone in one study (Morris et al, 1998) and only with combination of vitamin E and C in another one (Masaki et al, 2000) . More recently, other researches failed to find such an association between vitamin supplement intake and incident AD, but they have demonstrated a decreased risk of incident AD among subjects with high dietary intake of vitamins, particularly for vitamin E (Engelhart et al, 2002; Morris et al, 2002) .
Thus, an intake of antioxidant vitamins could help to prevent or delay dementia and needs to be explored further. Owing to the impact of vitamins E and A on oxidative stress, the present study assesses the relation between baseline plasma concentrations of vitamins A and E and the risk of developing a dementia in the subsequent 9 y. At the same time, plasma concentrations of malondialdehyde (MDA), a lipoperoxidation product and therefore an indicator of the oxidative stress level, are also analysed.
Subjects and methods

Patients
This study took place in the PAQUID (Personnes Agées QUID) research program which is an epidemiological study on normal and pathological aging after 65 y, particularly focused on nongenetic risk factors in dementia. A representative sample of 5554 individuals living at home in southwestern France was drawn, of whom 68% accepted to participate (ie 3777). Individuals were initially seen at home by a psychologist specially trained for home interviews and were then followed-up 1, 3, 5, 8, and 10 y after the baseline examination.
The baseline variables registered included sociodemographic factors, social support and network, living conditions and habits, subjective and objective health measures, a comprehensive functional assessment, depressive symptomatology, personal medical history, current symptoms and diseases, and neurosensory impairments. A more complete description of the baseline data collected in the PAQUID study has previously been published (Dartigues et al, 1991) .
Initially and at each follow-up, an active screening of dementia was performed. Intellectual functioning was examined through a series of psychometric tests, including the Mini Mental State Examination (MMSE) (Folstein et al, 1975) . After the psychometric evaluation, the psychologists systematically completed a standardized questionnaire designed to obtain the A (memory impairment), B (impairment of at least one other cognitive function), and C (interference with social or professional life) DSM-III R criteria for dementia (American Psychiatric Association, 1987) . Thereafter, individuals who met these first three DSM-III R criteria for dementia were seen by a senior neurologist who documented the diagnosis of dementia and its aetiology. An informant was consulted by the neurologist when available.
The present study is a nested case-control study. Eligible subjects were 626 within the PAQUID cohort who had a blood collection at a 1-y follow-up. Among them, 46 subjects developed an incident dementia within 2, 4, 7, or 9 y. For each case of dementia, three control subjects, nondemented at the time the case was diagnosed, were randomly matched by age and sex. For one case, only two controls were matched. In addition, one more control did not have enough serum to measure the vitamins and was excluded from the present analysis. Therefore, the sample was composed of 46 cases and 136 controls. After blood collection, blood samples were centrifuged at 1000 Â g and plasma was frozen at À1961C in liquid nitrogen.
Vitamins A (retinol) and E (tocopherol) analysis Vitamins A and E were quantified by reversed-phase highperformance liquid chromatography (HPLC). Briefly, 100 ml of plasma was mixed with 100 ml of retinyl acetate (1 mg/ml)/ alpha-tocopherol acetate (1 mg/ml)/ethanol, with 100 ml of ethanol, and with 400 ml of hexane. After vortexing for 30s, the mixture was centrifuged at 1000 Â g for 10 min. A total of 300 ml of the supernatant were dried under N 2 and the residue was treated with 100 ml of methanol. Finally, 25 ml samples were injected into a C18 mBondapack column (Waters, Ontario, Canada). Chromatography was carried out using methanol/water (98.5/1.5, v/v) as the mobile phase at a flow rate of 2 ml/min and absorbance was monitored at 290 nm on a Waters spectrophotometer (Lambda-max Model 486) (Peuchant et al, 1994) .
MDA analysis
Total MDA was analysed by a modified method by first using basic hydrolysis to release MDA bound to amino groups.
Association between antioxidants and the incidence of dementia C Helmer et al Secondly, the protein-free extract obtained after acid treatment reacted with thiobarbituric acid (TBA), and the MDA/ TBA adduct was separated from interfering chromogens by HPLC using an apparatus from Waters, Ontario, Canada (Carbonneau et al, 1991) . Quantification was obtained by fluorimetric detection. MDA concentrations were computed by reference to a calibration curve prepared by assays of tetraethoxypropane (Aldrich-Chemic, Steiheim, Germany) used as standard (Gutteridge, 1975) .
Statistical analysis
Comparisons between cases and controls were performed with w 2 tests for categorical variables and one-way analysis of variance for continuous variables. Relations between concentration of vitamins E, A, and MDA and incident dementia were analysed using logistic regression models. Odds ratios (OR) with 95% confidence interval (CI) (95%CI) are presented. Analyses were performed using the SAS program. We adjusted for potential confounding variables, which have been found to be associated with dementia and which could be associated with nutritional habits. Sociodemographic variables were considered: age (as a continuous variable), sex, education considered in two levels (at least primary school level validated by a diploma versus no diploma). Cognitive performances were assessed using the MMSE score. Habits included wine and tobacco consumption. Wine consumption per day was classified into three categories: no consumption (reference category), less than 1/ 4 l and more than 1/4 l. Smokers were classified into nonsmokers (reference category), former smokers, and current smokers. Hypertension was defined as having a reported systolic blood pressure equal to or greater than 160 mmHg and/or a diastolic blood pressure equal to or greater than 95 mmHg. Body mass index (BMI) (weight/height 2 ) was calculated. Finally, presence or absence of apolipoprotein E4 was considered.
Results
The study sample was composed of 46 demented cases and 136 controls. Among cases of dementia, 39 (84.8%) had an AD, three (6.5%) a vascular dementia, three (6.5%) a dementia with parkinsonism, and one (2.2%) another type of dementia. Characteristics of cases and controls are described in Table 1 . Among the 182 subjects, 114 were women. Mean age was 77.3 y (s.d.: 6.1). There was no significant difference between cases and controls according to age, sex, presence of apolipoprotein E4 allele, presence of hypertension, wine and tobacco consumption, BMI, or duration of follow-up. Compared to controls, cases were less educated (P ¼ 0.01) and had lower initial cognitive performances (P ¼ 0.04 adjusted for age, sex, and educational level). Plasma concentrations of vitamin E were lower among cases than controls (P ¼ 0.046). Vitamin A concentrations tended to be lower among cases (P ¼ 0.16), and MDA concentrations higher (P ¼ 0.15), but differences between cases and controls were not significant.
Plasma concentrations of vitamins E and A and MDA were split into tertiles. For both vitamins E and A, cases were overrepresented in the lowest tertile of the distribution (50% of cases for vitamin E and 43.5% for vitamin A) compared to control subjects (28.5% for vitamin E and 29.9% for vitamin A) (Figure 1 ). These lowest tertiles corresponded to a concentration equal to or lower than 21.0 mmol/l for vitamin E and 1.78 mmol/l for vitamin A. At the same time, cases were over-represented in the highest MDA tertile, corresponding to a value equal to or greater than 1.36 (43.5% of cases versus 29.9% of controls).
To analyse the risk of developing a dementia during the follow-up according to baseline concentrations of vitamins and MDA, logistic regression analyses were performed and were adjusted for age, sex, education, and apolipoprotein E4 (Table 2, Model 1). For vitamins E and A, the highest tertile of the distribution was the reference category. The risk of dementia was significantly increased among subjects in the lowest vitamin E tertile (OR ¼ 2.54, P ¼ 0.037), whereas the risk in the intermediate tertile was close to 1. Similar trends were observed for vitamin A, with an increased risk in the lowest vitamin A tertile, but this did not reach statistical significance (OR ¼ 2.10, P ¼ 0.095). As for vitamin E, the risk in the intermediate tertile was not significantly increased.
Adjustment for other potential confounding factors was made (Table 2, Model 2). However, because of missing data, these analyses were performed only in 156 subjects. Nevertheless, results were unchanged for vitamin E with an increased risk in the lowest vitamin E tertile (OR ¼ 3.12, Association between antioxidants and the incidence of dementia C Helmer et al P ¼ 0.033). The risks associated with vitamin A became nonsignificant. Similarly, high MDA concentrations tended to be associated, although not significantly, with an increased risk of dementia when adjusted for age, sex, education, and Apo E4 (OR ¼ 2.13 for the highest MDA tertile compared to the lowest one, P ¼ 0.09) (Table 2, Model 1). This risk decreased to 1.67 (P ¼ 0.31) in the reduced sample of 156 subjects when adjusted for other confounding factors (Table 2, Model 2).
A subanalysis has been performed for the 39 AD cases and their 115 controls (Table 3 , Models 1 and 2). Results for vitamin E were of the same order as those observed for allcause dementia, with a borderline significant increased risk of AD for subjects in the lowest tertile of vitamin E (OR ¼ 3.06, P ¼ 0.053). No association was found between vitamin A and AD. For MDA, the same trends as for all-cause dementia were shown, with a tendency to an increased risk for subjects in the highest tertile (OR ¼ 2.44, P ¼ 0.13).
Discussion
Our results suggest that subjects with low plasma concentrations of vitamin E are at higher risk of developing dementia in the subsequent years. Similarly, subjects with a high plasma MDA concentration tended to be at higher risk of developing a dementia.
These results are in favour of a role of an increased oxidative stress several years before the onset of dementia. The principal strength of our study is that it takes place within the framework of a prospective population-based study, where subjects have been followed-up for several years, with active screening of incident cases of dementia. Indeed, the onset of dementia is insidious and occurs several years before the clinical stage of the disease, which makes the interpretation of results difficult in cross-sectional studies. Nevertheless, the majority of the previous studies are crosssectional ones. In these studies, higher cognitive performances have been correlated with both high intake of carotenoids (Jama et al, 1996) and high plasmatic concentrations in carotenoids (Haller et al, 1996) , in vitamin C (Perrig et al, 1997) , or in vitamin E (Schmidt et al, 1998 , Perkins et al, 1999 . Concerning dementia, plasma antioxidant vitamin concentrations have been found to be lower in AD subjects compared with controls (Zaman et al, 1992; Riviere et al, 1998; Bourdel-Marchasson et al, 2001) . However, these studies did not adjust for potential confounders, particularly educational level, which is implicated in both an increased risk of AD (Letenneur et al, 1999) and feeding behaviour (Kilander & Ö hrvall, 1997) . Indeed, in our study, vitamin E concentrations were slightly higher among subjects who had at least a validated primary level of schooling (vitamin E ¼ 24.91 mmol/l) compared to those who had not (vitamin E ¼ 23.29 mmol/l), although this relation was not significant (P ¼ 0.12). Likewise, MDA concentrations were lower among subjects without the primary school level education (MDA ¼ 1.21 mmol/l compared to 1.28 mmol/l, P ¼ 0.053). In addition to cross-sectional studies, longitudinal studies have been published, which may help to answer the question whether the decrease in antioxidant plasma vitamins is either a cause or a consequence of the pathology; but results until now have not been totally concordant. Two observational studies have examined the relation between intake of vitamin supplements and incident dementia. In the report by Masaki et al (2000) , incidence of vascular dementia was decreased only among subjects taking both vitamins E and C, and no effect was observed for AD. On the contrary, Morris et al (1998) found an effect on incidence of AD associated with intake of vitamin C alone. Even if adjustment for several confounders is made, it is well known that subjects taking supplements differ from those who do not, in particular since they take greater interest in their health. Association between antioxidants and the incidence of dementia C Helmer et al intake of antioxidant, and/or the involvement of other nutritional phenomena in the reduction of the AD pathology. Two hypotheses can be formulated as the basis of the relation between vitamins and dementia or AD. (1) Firstly, deficient diet among older subjects can lead to an increase in oxidative stress because of a decreased capacity in antioxidant systems; this increase in oxidative stress promotes AD pathology and dementia. Moreover, the functional consequences of AD might even increase this nutritional deficiencies. Indeed, in the early stage of the disease, AD induces modifications of the habits and activities of the subjects, even before the disease can be clinically detected. In a previous paper from the PAQUID study, we found that instrumental activities of daily living were predictive of occurrence of dementia 3 y before the onset of the disease (Barberger-Gateau et al, 1999) . (2) The second possibility is that one of the first signs of AD could be an increase in oxidative stress, with depletion of antioxidant systems, particularly vitamins, owing to greater production of free Association between antioxidants and the incidence of dementia C Helmer et al radicals (Bourdel-Marchasson et al, 2001) . This decrease in antioxidant vitamins might then exacerbate oxidative stress leading to a progression of AD into a more severe disease. In our study, vitamin plasma concentrations were determined long before the diagnosis of dementia, up to 9 y before, that is, probably before the first signs of AD. Thus, low concentrations of antioxidant vitamins observed in our data are more likely a factor which could contribute to the occurrence of dementia rather than a consequence of this disease. However, despite our study design, few cases (11 cases among the 46) have developed dementia in the 2 y after the blood collection and could also be in an early stage of cognitive decline, as shown by the lowest initial cognitive performances observed among cases. To free ourself from that, we excluded cases who developed dementia in the 2 y after the blood collection and their controls; initial cognitive performances were no longer significantly different between cases and controls (P ¼ 0.36). Among this restricted sample, association between vitamin E and dementia persisted, with OR for the lowest tertile of vitamin E close (and even greater) to that observed in the total sample (OR ¼ 3.24, 95% CI (1.009-10.43), P ¼ 0.048).
We adjusted for several potential confounders of the relation between nutrients and dementia, particularly on the educational level. However, despite adjustments for these confounders, this may not account for all sources of bias. Indeed, higher education may be a surrogate for healthier practices such as diet, physical exercise, intellectual stimulation, better access to health care, or better management of risk factors, which cannot be taken into account. Another potential confounder is the apolipoprotein E status whose E4 allele represents a high risk factor of AD (Farrer et al, 1997) . The association between apoE4 and AD could be related to a decreased antioxidant capability; indeed, Rammassy et al (2002) found higher oxidative insults in the hippocampi of AD patients with ApoE4. In our study, we did not find any interaction between the effect of vitamins and apoE4 status (data not shown); however, the effect of apoE4 allele on dementia is lower after 70 y of age (Farrer et al, 1997) , and only a quarter of demented subjects were apoE4 carriers in our aged sample.
In the present elderly population, only two subjects were taking vitamin supplementation at baseline: vitamin E for one, and multivitamins for the other. As a result of the very low number of people under supplementation, this cannot have influenced plasma concentrations of vitamins in our study.
The mean plasma concentrations in vitamin E observed in our population can be considered as normal concentrations based on results from Meydani (1995) who defined the mean concentration as being 23 mmol/l. A greater mean value (30 mmol/l) was reported by Zaman et al (1992) among control subjects, but in a small sample of 20 subjects with large standard deviation. Only three subjects in our sample (two cases and one control) could be considered as deficient in vitamin E, when considering the cut-off of 11.6 mmol/l proposed by Meydani. Thus, even in the lowest tertile of the distribution, most of our subjects were not deficient in vitamin E, but only had low concentrations.
Our results showed that plasma vitamin E was significantly associated with the risk of dementia whereas only a tendency was observed for vitamin A. Similarly, high plasma MDA concentrations tended to be associated with a higher risk of dementia. The lack of significance for vitamin A could be because of insufficient statistical power. It could also be because of the hepatic regulation of this vitamin, which is stored in the liver, depending on the concentration of its binding protein. Besides, even if vitamin A has some antioxidant properties, it is not the most antioxidant of all, which can also be an explanation for our nonsignificant association.
In line with other studies, our findings support the oxidative stress hypothesis in dementia. Since previous studies have demonstrated that increasing intake of vitamins leads to an increase in plasma concentrations (Jacques et al, 1995; Kontush et al, 2001; McGavin et al, 2001) , and even in cerebrospinal fluid levels (Kontush et al, 2001) , the implication of our results could be the value of detecting subjects at higher risk of developing a dementia based on biological data (low vitamin E plasma concentration). Thus, vitamin E supplementation could be proposed to these subjects in order to help to prevent dementia, in addition to other modes of prevention. Although our results are specifically significant for vitamin E, other vitamins should also be considered, particularly vitamins A and C, since other authors have found interactions between the vitamins (Masaki et al, 2000 , Kontush et al, 2001 .
Until now, very few controlled trials have tested the efficacy of antioxidant vitamins supplementation, either on the cognitive performances with inconsistent results (Smith et al, 1999; Chandra, 2001) or on the functional progression among Alzheimer's subjects (Sano et al, 1997) . Recently, the Alzheimer's Disease Cooperative Study has initiated a multicentre clinical trial of vitamin E in elderly persons with Mild Cognitive Impairment, which aims to test whether vitamin E is effective in preventing or delaying AD (Grundman, 2000) . Future research should now develop trials to test the efficacy of vitamin supplementation in primary prevention of dementia among subjects with low levels of antioxidant vitamins.
